CHAPTER 3 Infection <strong>and</strong> Inflammation 39Figure 4. Schematic Illustration of Lipid-Mediated Pro-Inflammatory <strong>and</strong>Figure 4. Pro-Resolution Pathways(DHA). EPA <strong>and</strong> DHA can be metabolizedby aspirin-modified COX-2 pathways toform resolvins, while DHA can be convertedto protectins via an LO-mediated pathway(Figure 4).Another aspect of current anti-inflammatorystrategies was the discovery that disruptionof biosynthesis of these pro-resolutionmediators by either COX-2 or LOinhibitors may lead to a “resolution deficit”phenotype, which is characterized by impairedphagocyte removal, delayed resolution,<strong>and</strong> prolonged inflammation. This mayexplain why several anti-inflammatory agents,such as selective COX-2 inhibitors <strong>and</strong> certainLO inhibitors, have been shown to impairresolution of inflammation <strong>and</strong> lead to systemicinflammatory complications.Summary of Part IIITheoretically, combining pro- resolutionmediators <strong>and</strong> anti-inflammatory agents suchas aspirin <strong>and</strong> statins—agents that decreasethe extent of inflammation without inter -fering with the endogenous pro- resolu tionprocesses—may be a useful strategy to controlexcessive inflammation <strong>and</strong> restore homeo -stasis. More research is necessary to obtainsolid information on the efficacy <strong>and</strong> safetyof these interventions in humans. However,it is possible that in the future we can expectthat new treatment strategies will be availablefor the treatment of periodontal disease<strong>and</strong> its systemic complications.Supplemental ReadingsSerhan CN, Chiang N, Van Dyke TE. Resolving inflammation:dual anti-inflammatory <strong>and</strong> pro-resolutionlipid mediators. Nat Rev Immunol 2008;8(5):349–61.Madianos PN, Bobetsis YA, Kinane DF. Generation ofinflammatory stimuli: how bacteria set up inflammatoryresponses in the gingiva. J Clin Periodontol 2005;32(Suppl 6):57–71.Loos BG. Systemic markers of inflammation in perio -dontitis. J Periodontol 2005;76(Suppl 11):2106–2115.Ridker PM, Silvertown JD. Inflammation, C-reactiveprotein, <strong>and</strong> atherothrombosis. J Periodontol 2008;79(Suppl 8):1544–1551.REFERENCES1. Löe H, Theilade E, Jensen SB. Experimental gingivitisin man. J Periodontol 1965;36:177–187.
40 <strong>Periodontal</strong> <strong>Disease</strong> <strong>and</strong> <strong>Overall</strong> <strong>Health</strong>: A <strong>Clinician's</strong> <strong>Guide</strong>2. Ridker PM, Silvertown JD. Inflammation, C-reactiveprotein, <strong>and</strong> atherothrombosis. J Periodontol2008;79:1544–1551.3. Lohsoonthorn V, Qiu C, Williams MA. Maternalserum C-reactive protein concentrations in earlypregnancy <strong>and</strong> subsequent risk of preterm delivery.Clin Biochem 2007;40:330–335.4. Pradhan AD, Manson JE, Rifai N, Buring JE,Ridker PM. C-reactive protein, interleukin 6, <strong>and</strong>risk of developing type 2 diabetes mellitus. JAMA2001;286:327–334.5. Serhan CN, Chiang N, Van Dyke TE. Resolvinginflammation: dual anti-inflammatory <strong>and</strong> proresolutionlipid mediators. Nat Rev Immunol 2008;8:349–361.6. Paster BJ, Olsen I, Aas JA, Dewhirst FE. Thebreadth of bacterial diversity in the human perio -dontal pocket <strong>and</strong> other oral sites. Periodontol 20002006;42:80–87.7. Haffajee AD, Cugini MA, Tanner A, Pollack RP,Smith C, Kent RL Jr, Socransky SS. Subgingivalmicrobiota in healthy, well-maintained elder <strong>and</strong>periodontitis subjects. J Clin Periodontol 1998;25:346–353.8. Madianos PN, Bobetsis YA, Kinane DF. Generationof inflammatory stimuli: How bacteria set up inflammatoryresponses in the gingiva. J Clin Perio -dontol 2005;32(Suppl 6):57–71.9. S<strong>and</strong>ros J, Papapanou PN, Nannmark U, Dahlén G.Porphyromonas gingivalis invades human pocketepithelium in vitro. J <strong>Periodontal</strong> Res 1994;29:62–69.10. Takada H, Mihara J, Morisaki I, Hamada S. Inductionof interleukin-1 <strong>and</strong> -6 in human gingival fibro -blast cultures stimulated with Bacteroides lipopoly -saccharides. Infect Immun 1991;59:295–301.11. Supajatura V, Ushio H, Nakao A, Akira S, OkumuraK, Ra C, Ogawa H. Differential responses of mastcell Toll-like receptors 2 <strong>and</strong> 4 in allergy <strong>and</strong> innateimmunity. J Clin Invest 2002;109:1351–1359.12. Darveau RP, Cunningham MD, Bailey T, SeachordC, Ratcliffe K, Bainbridge B, Dietsch M, Page RC,Aruffo A. Ability of bacteria associated with chronicinflammatory disease to stimulate E- selectin expression<strong>and</strong> promote neutrophil adhesion. InfectImmun 1995;63:1311–1317.13. Weissmann G, Smolen JE, Korchak HM. Release ofinflammatory mediators from stimulated neutro -phils. N Engl J Med 1980;303:27–34.14. Page RC, Schroeder HE. Pathogenesis of inflammatoryperiodontal disease. A summary of currentwork. Lab Invest 1976;34:235–249.15. Kinane DF, Karim SN, Garioch JJ, al Badri AT,Moughal N, Goudie RB. Heterogeneity <strong>and</strong> selectivelocalisation of T cell clones in human skin <strong>and</strong>gingival mucosa. J <strong>Periodontal</strong> Res 1993;28:497–499.16. Kawai T, Paster BJ, Komatsuzawa H, Ernst CW,Goncalves RB, Sasaki H, Ouhara K, Stashenko PP,Sugai M, Taubman MA. Cross-reactive adaptiveimmune response to oral commensal bacteria resultsin an induction of receptor activator of nuclearfactor-kappaB lig<strong>and</strong> (RANKL)-dependent perio -dontal bone resorption in a mouse model. OralMicro biol Immunol 2007;22:208–215.17. Tanner AC, Kent R Jr, Kanasi E, Lu SC, Paster BJ,Sonis ST, Murray LA, Van Dyke TE. Clinicalcharacteristics <strong>and</strong> microbiota of progressing slightchronic periodontitis in adults. J Clin Periodontol2007;34:917–930.18. Kinane DF, Riggio MP, Walker KF, MacKenzie D,Shearer B. Bacteraemia following periodontal procedures.J Clin Periodontol 2005;32:708–713.19. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemicdiseases caused by oral infection. Clin MicrobiolRev 2000;13:547–558.20. Jain A, Batista EL Jr, Serhan C, Stahl GL, VanDyke TE. Role for periodontitis in the progressionof lipid deposition in an animal model. InfectImmun 2003;71:6012–6018.21. Thoden van Velzen SK, Abraham-Inpijn L, MoorerWR. Plaque <strong>and</strong> systemic disease: A reappraisalof the focal infection concept. J Clin Periodontol1984;11:209–220.22. Amar S, Gokce N, Morgan S, Loukideli M, VanDyke TE, Vita JA. <strong>Periodontal</strong> disease is associatedwith brachial artery endothelial dysfunction <strong>and</strong>systemic inflammation. Arterioscler Thromb VascBiol 2003;23:1245–1249.23. Ridker PM, Danielson E, Fonseca FA, Genest J,Gotto AM Jr, Kastelein JJ, Koenig W, Libby P,Lorenzatti AJ, MacFadyen JG, Nordestgaard BG,Shepherd J, Willerson JT, Glynn RJ; JUPITERStudy Group. Rosuvastatin to prevent vascularevents in men <strong>and</strong> women with elevated C-reactiveprotein. N Engl J Med 2008;359:2195–2207.24. Casey R, Newcombe J, McFadden J, Bodman-Smith KB. The acute-phase reactant C-reactiveprotein binds to phosphorylcholine-expressingNeisseria meningitidis <strong>and</strong> increases uptake byhuman phagocytes. Infect Immun 2008;76:1298–1304.25. Nakakuki T, Ito M, Iwasaki H, Kureishi Y, OkamotoR, Moriki N, Kongo M, Kato S, Yamada N, IsakaN, Nakano T. Rho/Rho-kinase pathway contributesto C-reactive protein-induced plasminogen acti -vator inhibitor-1 expression in endothelial cells.Arterioscler Thromb Vasc Biol 2005;25:2088–2093.26. Janeway C., Travers P., Walport M., Shlomchik M.Immunobiology. The immune system in health <strong>and</strong>